about
Cytokine-induced neutrophil-mediated injury of human endothelial cellsDifferential induction of BLT receptor expression on human endothelial cells by lipopolysaccharide, cytokines, and leukotriene B4Are omega-3 fatty acids options for prevention and treatment of cognitive decline and dementia?HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease)A 40-base-pair duplication in the gp91-phox gene leading to X-linked chronic granulomatous diseaseNormal levels of constitutive and death receptor-mediated apoptosis of peripheral blood neutrophils from patients with chronic idiopathic neutropenia.Late-onset neutropenia associated with rituximab therapy: evidence for a maturation arrest at the (pro)myelocyte stage of granulopoiesis.X-linked thrombocytopenia with thalassemia displays bone marrow reticulin fibrosis and enhanced angiogenesis: comparisons with primary myelofibrosis.Adverse effects and benefits of two years of anagrelide treatment for thrombocythemia in chronic myeloproliferative disorders.Idiosyncratic drug-induced agranulocytosis: possible mechanisms and management.Comparison of daunorubicin and daunorubicin-DNA complex in the treatment of acute nonlymphoblastic leukemia.Neutrophil functions and clinical performance after total fasting in patients with rheumatoid arthritis.Gamma interferon treatment of patients with chronic granulomatous disease is associated with augmented production of nitric oxide by polymorphonuclear neutrophils.Reduced prostaglandin F2 alpha release from blood mononuclear leukocytes after oral supplementation of omega3 fatty acids: the OmegAD study.Late-onset neutropenia following rituximab therapy in rheumatic diseases: association with B lymphocyte depletion and infections.Dominant expression of the CysLT2 receptor accounts for calcium signaling by cysteinyl leukotrienes in human umbilical vein endothelial cells.Effects of DHA-rich n-3 fatty acid supplementation on gene expression in blood mononuclear leukocytes: the OmegAD study.ω-3 fatty acids in the prevention of cognitive decline in humans.Development and characterization of essential fatty acid deficiency in human endothelial cells in culture.Resolution of inflammation is altered in Alzheimer's diseaseSearching the haematology and inflammation archives of Journal of Internal Medicine.Effects of n-3 FA supplementation on the release of proresolving lipid mediators by blood mononuclear cells: the OmegAD studyBone marrow in polycythemia vera, chronic myelocytic leukemia, and myelofibrosis has an increased vascularity.Disturbed interaction of p21-rac with mutated p67-phox causes chronic granulomatous diseaseKostmann syndrome or infantile genetic agranulocytosis, part two: Understanding the underlying genetic defects in severe congenital neutropenia.Mutations in the granulocyte colony-stimulating factor receptor gene in patients with severe congenital neutropenia.Leukotriene biosynthesis by polymorphonuclear leukocytes from two patients with chronic granulomatous disease.Antirheumatic effects of fasting.Assignment of the gene locus for severe congenital neutropenia to chromosome 1q22 in the original Kostmann family from Northern Sweden.Effect of FCGR polymorphism on the occurrence of late-onset neutropenia and flare-free survival in rheumatic patients treated with rituximab.Plasma Fatty Acid Profiles in Relation to Cognition and Gender in Alzheimer's Disease Patients During Oral Omega-3 Fatty Acid Supplementation: The OmegAD Study.DHA-rich n-3 fatty acid supplementation decreases DNA methylation in blood leukocytes: the OmegAD study.Omega-3 fatty acids enhance phagocytosis of Alzheimer's disease-related amyloid-β42 by human microglia and decrease inflammatory markers.Effect of dietary lipids on immunity and inflammation. Review article.Impaired leukotriene C4 generation in granulocytes from protein-energy malnourished chronically ill elderly.The erythrocyte sedimentation rate and stress.Involvement of a functional NADPH oxidase in neutrophils and macrophages during programmed cell clearance: implications for chronic granulomatous disease.Kostmann syndrome or infantile genetic agranulocytosis, part one: celebrating 50 years of clinical and basic research on severe congenital neutropenia.Oral acyclovir as prophylaxis for bacterial infections during induction therapy for acute leukaemia in adults. The Leukemia Group of Middle Sweden.Ceftazidime as initial therapy in febrile patients with acute leukemia during induction chemotherapy. Leukemia Group of Middle Sweden.
P50
Q24316895-F63B9AFD-33A9-4300-9AEC-1DD1685E28F4Q24543690-EA8DB468-34A8-4324-A448-F6656F482864Q28268060-4FD6663A-BB25-44C8-8D28-A9A45F347FB1Q28280427-4636F2B6-CD29-4298-8395-188193E9CC17Q28298632-1E615A06-422D-471C-8E86-BF942DC5F4FDQ33267588-E52819FE-5099-4C7D-B746-30CF1746C89FQ33320029-5F0B41E5-C7F2-4F2B-A93C-93EF2DC6AE95Q33418847-EA368311-6D0F-45F6-8B91-4A57AA223142Q33431619-248D2EB3-6639-4635-B563-D720DEE8D79DQ33449520-6E7709EA-8989-424F-83E3-8281354895D7Q33483724-A9F9ED92-558A-411E-BCBE-E3C1A33D8A95Q33554060-29164AD2-A566-4BCB-83D9-981C8B71E5E0Q33637370-EC01F307-0DC9-426C-BBBF-CED884A25559Q33784535-87782BD9-6E3A-4228-BB49-B3A1BE3256D6Q33895391-23AD7274-A473-4B6F-8CFA-280BF0F10734Q34207335-A8980A78-124E-4559-B45F-D66DFD832BE6Q34251118-197ABB15-F4FD-4B17-8851-7FCC85C093D7Q34384913-252C66CA-FFC7-4EA5-BBF4-AD91C6671B8EQ34695706-FC6CC339-12CF-4A79-BE14-C88D587CDF24Q34765889-AB7D7C57-98EC-40BA-86FB-10B45246E778Q34984984-D9703A2D-EF3F-4316-BF43-DC9F83454D22Q35120950-638DC6B3-9625-4D6C-A8A0-9E9098225B83Q35745897-5DD6C2CB-D2F1-495C-8679-23198E612870Q36367432-5D880B72-6874-4828-A881-1ED2BC4B9F47Q36834992-026C704A-E480-4C69-BAC5-099DA25939E7Q36842776-0BDA88D8-6D14-4D70-8F70-0BAFCC50CE7CQ36992569-A22971B0-7FC8-4F8E-AC85-20D63BCBB90AQ37214590-B7424C34-3B33-4B77-AB38-58CAE294B4FCQ37292153-1586D946-8B74-4DDB-AD48-69297C78916BQ37686026-A2506561-5C60-4312-A24F-29B39DCD0B66Q38403214-9C66CAB6-E299-4F77-B608-F0356258CFF1Q38601719-8E371337-3B03-4976-B27A-4CF3F516807BQ39182204-195AA386-6F6A-4C4B-B2D3-B38BB2261BE3Q39248546-61AA1E70-1137-4154-AA2A-548494273D80Q39541210-28A8A4F1-A48C-409D-ABDE-AA8B6D421B9AQ39552653-F63A1C62-B660-4F28-80F1-2CE8A16F4260Q39830520-C236F12B-24C2-4888-B15E-610B3D410488Q40266139-CDAA61DC-A38A-40A8-ABD4-3406F3CC7A88Q40718733-A9FA1A60-EB97-45A9-A575-CAC2830729E9Q40739131-8766729A-9E56-45F2-BA13-2D6B8BCAECE4
P50
description
Swedish researcher
@en
Zweeds onderzoeker
@nl
svensk forsker
@nb
taighdeoir Sualannach
@ga
name
Jan Palmblad
@ast
Jan Palmblad
@da
Jan Palmblad
@de
Jan Palmblad
@en
Jan Palmblad
@es
Jan Palmblad
@fr
Jan Palmblad
@ga
Jan Palmblad
@nb
Jan Palmblad
@nl
Jan Palmblad
@nn
type
label
Jan Palmblad
@ast
Jan Palmblad
@da
Jan Palmblad
@de
Jan Palmblad
@en
Jan Palmblad
@es
Jan Palmblad
@fr
Jan Palmblad
@ga
Jan Palmblad
@nb
Jan Palmblad
@nl
Jan Palmblad
@nn
prefLabel
Jan Palmblad
@ast
Jan Palmblad
@da
Jan Palmblad
@de
Jan Palmblad
@en
Jan Palmblad
@es
Jan Palmblad
@fr
Jan Palmblad
@ga
Jan Palmblad
@nb
Jan Palmblad
@nl
Jan Palmblad
@nn
P214
P21
P214
P27
P31
P496
0000-0003-4014-2540
P735
P7859
lccn-n2010183336